UK Markets closed

Global Alpha-1 Antitrypsin Drugs Market Trajectory & Analytics Report 2021: Market to Reach $2 Billion by 2027 - U.S. Market is Estimated at $319.3 Million, While China is Forecast to Grow at 9% CAGR - ResearchAndMarkets.com

·2-min read

The "Alpha-1 Antitrypsin Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Alpha-1 Antitrypsin Drugs Market to Reach $2 Billion by 2027

Amid the COVID-19 crisis, the global market for Alpha-1 Antitrypsin Drugs estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 9.6% over the period 2020-2027.

The U.S. Market is Estimated at $319.3 Million, While China is Forecast to Grow at 9% CAGR

The Alpha-1 Antitrypsin Drugs market in the U.S. is estimated at US$319.3 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$354.1 Million by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

(Total 43 Featured):

  • Abeona Therapeutics

  • Alnylam Pharmaceuticals

  • Applied Genetic Technologies Corp

  • Arrowhead Research Corporation

  • Baxalta

  • Baxter

  • CSL Behring

  • Grifols

  • Kamada

  • Shire

  • Takeda Pharmaceutical Company Limited

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

  • World Current & Future Analysis for Alpha-1 Antitrypsin Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

  • World Historic Review for Alpha-1 Antitrypsin Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

  • World 15-Year Perspective for Alpha-1 Antitrypsin Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 43

For more information about this report visit https://www.researchandmarkets.com/r/ydf33k

View source version on businesswire.com: https://www.businesswire.com/news/home/20210419005646/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900